home / stock / bfra / bfra news

BFRA News and Press, Biofrontera AG From 12/20/19

Stock Information
Company Name: Biofrontera AG
Stock Symbol: BFRA
Market: NASDAQ
Menu
BFRA BFRA Quote BFRA Short BFRA News BFRA Articles BFRA Message Board
Get BFRA Alerts

News, Short Squeeze, Breakout and More Instantly...
BFRA - Extraordinary General Meeting of Biofrontera AG: Biofrontera Management Board supported by large majority

Leverkusen, Germany, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced the results of the Extraordinary General Meeting held on December 19, 2019. The shar...
BFRA - Christopher Pearson appointed new Chief Commercial Officer at US subsidiary Biofrontera Inc.

Leverkusen, Germany, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that Christopher Pearson has accepted the appointment as Chief Commercial Officer of...

BFRA - Biofrontera (BFRA) Presents At German Equity Forum 2019 - Slideshow

The following slide deck was published by Biofrontera AG in conjunction with this Read more ...

BFRA - Biofrontera to Participate in Upcoming Investor Conferences

Leverkusen, Germany, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the "Company"), an international biopharmaceutical company, today announced its participation at the following events: Event: Deutsches Eigenkapitalforum / Analyst confe...
BFRA - Biofrontera AG (BFRA) CEO Hermann Lübbert on Q3 2019 Results - Earnings Call Transcript

Biofrontera AG (BFRA) Q3 2019 Results Earnings Conference Call November 19, 2019, 08:00 AM ET Company Participants Pamela Keck - Head of Investor Relations Hermann Lübbert - Chief Executive Officer Thomas Schaffer - Chief Financial Officer Conference Call Participants ...

BFRA - Biofrontera reports 9M results

Biofrontera (NASDAQ: BFRA ): 9M GAAP EPS of -€0.06. Revenue of €19.06M (+31.0% Y/Y) Press Release More news on: Biofrontera AG, Earnings news and commentary, Healthcare stocks news,

BFRA - Biofrontera Reports Third Quarter 2019 Financial Results and Revises Guidance

Leverkusen, Germany, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced its results for the first nine months ended September 30, 2019. At the same time, th...
BFRA - Biofrontera Announces Conference Call on November 19, 2019 to Discuss Third Quarter 2019 Financial Results

Leverkusen, Germany, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its financial results for the first nine months ended September 30, 2019 on Novemb...

BFRA - Biofrontera Receives Award at Fall Clinical Dermatology Conference 2019

Leverkusen, Germany, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, was presented with the "Poster of the Day" award at the renowned Fall Clinical Dermatology Conferenc...

BFRA - Biofrontera reports preliminary unaudited sales revenue for the first nine months of 2019

Leverkusen, Germany, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-group”), an international biopharmaceutical company, today reports preliminary unaudited revenue for the third q...
Previous 10 Next 10